Ealixir, Inc.
EAXR · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3,625 | $5,052 | $4,140 | $3,538 |
| % Growth | -28.2% | 22% | 17% | – |
| Cost of Goods Sold | $495 | $1,307 | $877 | $864 |
| Gross Profit | $3,130 | $3,744 | $3,263 | $2,674 |
| % Margin | 86.3% | 74.1% | 78.8% | 75.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $4,700 | $2,939 | $2,844 |
| SG&A Expenses | $3,534 | $4,720 | $2,992 | $3,556 |
| Sales & Mktg Exp. | $0 | $20 | $54 | $159 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3,534 | $4,720 | $2,992 | $3,556 |
| Operating Income | -$405 | -$976 | $270 | -$882 |
| % Margin | -11.2% | -19.3% | 6.5% | -24.9% |
| Other Income/Exp. Net | $0 | -$480 | -$110 | $597 |
| Pre-Tax Income | $126 | -$1,456 | $160 | -$285 |
| Tax Expense | $30 | -$516 | $20 | $48 |
| Net Income | $96 | -$1,189 | $140 | -$335 |
| % Margin | 2.6% | -23.5% | 3.4% | -9.5% |
| EPS | 0.002 | -0.015 | 0.003 | -0.007 |
| % Growth | 111% | -600% | 139.7% | – |
| EPS Diluted | 0.002 | -0.015 | 0.003 | -0.007 |
| Weighted Avg Shares Out | 60,282 | 58,557 | 48,082 | 45,599 |
| Weighted Avg Shares Out Dil | 60,282 | 58,554 | 48,082 | 45,599 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $25 | $35 | $27 | $0 |
| Depreciation & Amortization | $84 | $85 | $76 | $42 |
| EBITDA | $235 | -$1,336 | $263 | -$243 |
| % Margin | 6.5% | -26.5% | 6.3% | -6.9% |